Growth potential Longs Pharmacy Solutions operates across fifteen states with licensure nationwide and a portfolio including Longs Drugs, Longs Specialty, and Avita Pharmacy. This breadth signals opportunities to upsell enterprise pharmacy services, 340B contract pharmacy capabilities, and integrated solutions to doctors, health systems, and payors seeking scalable pharmacy partnerships.

340B & partnerships As a 340B contract pharmacy administrator, Longs has established collaboration with service organizations and payors. Sales opportunities exist to expand 340B program management, compliance, and optimization services for additional hospitals, clinics, and health networks looking to maximize 340B benefits.

Tech-enabled A technology stack featuring MySQL, jQuery, and modern web tools suggests a capability to integrate with healthcare IT systems. This presents cross-sell potential for pharmacy IT integrations, data analytics, and customer portal enhancements to streamline operations for provider partners and payors.

Financial signal Revenue tier of one to ten million indicates a mid-market profile with room for growth through expanded retail and specialty pharmacy contracts, managed care collaborations, and expanded 340B contracts with hospitals seeking proven partner networks.

Competitive positioning Compared to industry giants, Longs positions as a specialized partner with a broad geographic reach and focus on both specialty and retail pharmacy. This suggests opportunities to pitch targeted solutions for complex medication management, specialty drug fulfillment, and provider-to-pharmacist coordination to win mid-market accounts seeking personalized service.